Effects of the Tyrosine Kinase Inhibitor, Imatinib Mesylate on a Bcr-Abl-Positive Cell Line : Suppression of Autonomous Cell Growth but No Effect on Decreased Adhesive Property and Morphological Changes.
Kyoto University (京都大学) === 0048 === 新制・課程博士 === 博士(医学) === 甲第10699号 === 医博第2683号 === 新制||医||853(附属図書館) === UT51-2004-G546 === 京都大学大学院医学研究科内科系専攻 === (主査)教授 前川 平, 教授 下遠野 邦忠, 教授 内山 卓 === 学位規則第4条第1項該当...
Main Author: | Nishihara, Toshio |
---|---|
Other Authors: | 前川, 平 |
Format: | Others |
Language: | English |
Published: |
Kyoto University
2011
|
Subjects: | |
Online Access: | http://hdl.handle.net/2433/147461 |
Similar Items
-
A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL positive human leukemic cells : caspase-independent, necrosis-like programmed cell death mediated by serine protease activity
by: Okada, Masayuki
Published: (2011) -
Inhibition of BCR/ABL protein expression by miR-203 sensitizes for imatinib mesylate.
by: Yajuan Li, et al.
Published: (2013-01-01) -
Evaluating the effect of imatinib mesylate in chronic myeloid leukemia patients in the expression of JunB and BCR-ABL gene
by: Yi-Chang Liu, et al.
Published: (2003) -
INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph[+] leukemia cells in the central nervous system, and cyclosporine A augments its in vivo activity
by: Yokota, Asumi
Published: (2010) -
Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients
by: Marjanu Hikmah Elias, et al.
Published: (2012-11-01)